One of our Bird Flu Basket holdings is Hemispherx Biopharma ("HEB"), courtesy of Ilene's research. Today HEB announced a Research Agreement with the Canadian Department of National Defence (their spelling, not ours). Although the stock is up 3% on the news, it may be that the news is worth a whole lot more then 3%. If so, it spells buying opportunity. I added to my position already and may add more after I post this. Good Luck.